LINC-P21, a long non-coding RNA known to be upregulated in patients with type 2 diabetes mellitus (T2D), has been shown to inhibit the expression of miR-766-3p, thereby upregulating MR expression in pancreatic islet cells. This evidence concerns the gene NR3C2 and type 2 diabetes mellitus.